The role of estrogens in melanoma susceptibility and malignancy remained controversial, due to the reported contradictory experimental and clinical findings: estradiol enhances tumor growth and metastasis in B16 melanoma cells, but in human malignant melanoma biopsies, the expressions of estrogen receptors ERα and ERβ are decreased [14]. Here, ESR2 is linked to neoplasm.